Please take a moment to review the latest ASCO News
- ASCO Member Testifies Before Congress Urging Significant Increase in Federal Cancer Research Funding
- New Comments to Congress Call for Strengthening Oncology Workforce
- Reduced Beneficiary Coinsurance for 27 Part B Drugs in Effect April 1; Includes Cancer Drugs
- Strengthen the Strategic National Stockpile to Protect Individuals With Cancer in Future Emergencies
- Electronic Prior Authorization Processes Must Be Expedited and Include Cancer Drug Treatments
- ASCO Volunteers Join Cancer Research Lobby Day on Capitol Hill
- President Biden Prioritizes Cancer Research, Access to Care in FY 2024 Budget Proposal
- FDA Expands Early Breast Cancer Indication for Abemaciclib with Endocrine Therapy
- Medical Institutions in Sub-Saharan Africa Now Invited to Apply to Host the International Cancer Corps
- DEA Proposes Permanent Telemedicine Flexibilities for Prescribing Controlled Medications
- Timeline for Unwinding the COVID-19 Public Health Emergency
- Three Models Testing Ways to Lower Drug Costs Outlined in Health and Human Services Report
- Eight Oncology Health Systems Participating in Efforts to Improve Vaccination Rates Among High-Risk Adults
- Legislation to Increase PBM Transparency and Lower Out-of-Pocket Costs Introduced in Congress
- Estimated Impact of 2023 Medicare Physician Reimbursement Cuts Now -1% for Hematology/Oncology